Abstract
Objectives: A meta-analysis of traditional Chinese medicine in the treatment of acute migraine was conducted to obtain a consistent evaluation of its efficacy. Methods: The search databases were China National Knowledge Infrastructure (CNKI), Wanfang, VIP, Chinese Biomedical Literature Database (CBM) and PubMed. The publication time of randomized controlled studies (RCT) documents is limited to before June 30, 2023. Results: Data from 399 patients from 5 RCTs were included. Compared with Western medicine, Traditional Chinese medicine has a higher efficacy ([RR=0.81, 95%CI (0.75, 0.89), P<0.00001]), a lower adverse reaction rate ([RR=1.37, 95%CI (0.74, 2.54), P=0.32]) and an improved VAS ([MD=-1.37, 95%CI (-2.00, -0.75), P<0.00001]). Conclusion: Traditional Chinese medicine in the treatment of acute migraine can enhance clinical efficacy, reduce treatment side effects, and improve patients’ visual analogue score.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
